Dihydroartemisinin

Qinghaosu (artemisinin): an antimalarial drug from China: D.L. Klayman; Science 228, 1049 (1985) | Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model: C. J. Janse, et al.; Int. J. Parasitol. 24, 589 (1994) | The development of the antimalarial drugs with new type of chemical structure--qinghaosu and dihydroqinghaosu: Y. Tu; SE Asian J. Trop. Med. Publ. Health 35, 250 (2004) | Artemisinin induces apoptosis in human cancer cells: N.P. Singh & H.C. Lai; Anticancer Res. 24, 2277 (2004) | Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-kappaB pathway in microglia cells: C. Zhu, et al.; PLoS One 7, e35125 (2012) | In vivo activity of dihydroartemisinin against Schistosoma mansoni schistosomula in mice: H.J. Li, et al.; SE Asian J. Trop. Med. Publ. Health 44, 379 (2013) | Differential effect of artemisinin against cancer cell lines: M. Tilaoui, et al.; Nat. Prod. Bioprospect. 4, 189 (2014) | Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats: D. Yang, et al.; Int. J. Clin. Exp. Pathol. 8, 1270 (2015) | Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy: Z.S. Zhang, et al.; Oncol. Lett. 10, 379 (2015) | Artemisinins target GABAA receptor signaling and impair alpha cell identity: J. Li, et al.; Cell 168, 86 (2017) | EXP1 is critical for nutrient uptake across the parasitophorous vacuole membrane of malaria parasites: P. Mes?n-Ram?rez, et al.; PLoS Biol. 17, e3000473 (2019) | Anti-SARS-CoV-2 Potential of Artemisinins In Vitro: R. Cao, et al.; ACS Infect. Dis. 6, 2524 (2020)